Roy S. Herbst, Worta McCaskill-Stevens, and Lawrence N. Shulman received awards from the Association of Community Cancer Centers.
Herbst received the 2020 Clinical Research Award. Herbst is Ensign Professor of Medicine, professor of pharmacology, chief of medical oncology and associate director for translational research at the Yale Cancer Center and Smilow Cancer Hospital.
Herbst’s work focuses on the identification of biomarkers and bringing novel targeted treatments and immunotherapies to patients. He has served as principal investigator for clinical trials testing these agents in advanced stage lung cancers. His work has led to the approval of several therapies.
Herbst’s work on “umbrella” trials prompted FDA approvals of targeted therapies and new cancer drugs. Nationally, he works closely with public-private partnerships to develop large master protocol clinical studies, such as Lung-MAP.
ACCC’s Clinical Research Award recognizes individuals whose research has significantly and positively impacted oncology patients, their families, caregivers and communities. Herbst was selected for his distinguished career in lung cancer research and track record of successfully integrating clinical, laboratory and research programs to bring new treatments to cancer therapy.
McCaskill-Stevens has received the 2020 David King Community Clinical Scientist Award.
McCaskill-Stevens is a medical oncologist and chief of the Community Oncology and Prevention Trials Research Group at NCI, Division of Cancer Prevention, NCI Community Oncology Research Program.
McCaskill-Stevens’s work focuses on cancer disparities, management of comorbidities within clinical trials, and molecular research to identify individuals who will benefit most from cancer prevention interventions.
The ACCC David King Community Clinical Scientist Award recognizes active community clinical research leaders who have demonstrated leadership in the development, participation and evaluation of clinical studies, and who are active in the development of new screening, risk assessment, treatment or supportive care programs for cancer patients.
Shulman received the 2020 Annual Achievement Award. Shulman is professor of Medicine at the Perelman School of Medicine, deputy director for Clinical Services and director of the Center for Global Cancer Medicine at the Abramson Cancer Center, University of Pennsylvania.
Shulman was recognized for not only his esteemed work as a breast oncologist and oncology-practice thought leader, teacher and mentor, but for his generous approach that drives others in the oncology profession from around the world to seek his counsel.
Shulman has a long history of work in low-resourced areas throughout the United States and internationally, including the promotion of early detection and establishment and maintenance of cancer treatment programs.
Since 1980, the ACCC Annual Achievement Award has recognized distinguished individuals or organizations that reflect the values of community cancer care through their outstanding contributions.
